A new paradigm for lymph node regeneration via cell-based drug delivery systems

Key Points

• To explore the potential of cell-based drug delivery systems in regenerating lymph nodes and addressing lymphatic diseases.
• Developed artificial lymph tissue (CeLyT) using centrifugation for enhanced tissue architecture.
• Implanted CeLyT into mouse models to assess lymph node regeneration.
• Evaluated tissue organization and functionality post-implantation.
• Demonstrated creation of highly organized functional lymph node-like tissue post-implantation.
• Improved tissue integration and immune microenvironment stabilization observed.
• Offers promising strategies to address unresolved issues in lymphatic diseases.

Abstract